-
1دورية أكاديمية
المؤلفون: Vergel N; Director, Program for Wellness Restoration, Houston, Texas.; Community Member, Delaney AIDS Research Enterprise (DARE), Houston, Texas.
المصدر: HIV research & clinical practice [HIV Res Clin Pract] 2024 Dec; Vol. 25 (1), pp. 2328408. Date of Electronic Publication: 2024 Mar 23.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Taylor & Francis Group Country of Publication: England NLM ID: 101738312 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2578-7470 (Electronic) Linking ISSN: 25787470 NLM ISO Abbreviation: HIV Res Clin Pract Subsets: MEDLINE
مواضيع طبية MeSH: HIV Infections*/drug therapy, Humans ; HIV Long-Term Survivors
-
2دورية أكاديمية
المؤلفون: Benito JM; HIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.; Hospital Universitario Rey Juan Carlos, 28933 Móstoles, Spain., Jiménez-Carretero D; Unidad de Bioinformática, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain., Restrepo C; HIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.; Hospital Universitario Rey Juan Carlos, 28933 Móstoles, Spain., Ligos JM; Cytek Biosciences, Inc., Fremont, CA 94538, USA., Valentín-Quiroga J; Grupo de Respuesta Inmune Innata, IdiPAZ, Hospital Universitario La Paz, 28046 Madrid, Spain., Mahillo I; Department of Statistics, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain., Cabello A; Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain., López-Collazo E; Grupo de Respuesta Inmune Innata, IdiPAZ, Hospital Universitario La Paz, 28046 Madrid, Spain., Sánchez-Cabo F; Unidad de Bioinformática, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain., Górgolas M; Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain., Estrada V; Hospital Universitario Clínico San Carlos, 28040 Madrid, Spain., Rallón N; HIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.; Hospital Universitario Rey Juan Carlos, 28933 Móstoles, Spain.
مؤلفون مشاركون: ECRIS Integrated in the Spanish AIDS Research Network
المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 May 29; Vol. 25 (11). Date of Electronic Publication: 2024 May 29.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
مواضيع طبية MeSH: HIV Infections*/immunology , HIV Infections*/drug therapy , HIV Infections*/virology , Homeostasis* , CD4-Positive T-Lymphocytes*/immunology , CD8-Positive T-Lymphocytes*/immunology, Humans ; Male ; Female ; Adult ; Middle Aged ; HIV Long-Term Survivors ; HIV-1/immunology ; Cohort Studies ; Viral Load
-
3دورية أكاديمية
المؤلفون: Ni W; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Ren L; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Liao L; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Li D; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Luo Z; Autoimmune Department, BioRay Pharmaceutical Co., Ltd., San Diego, CA, United States., Zhu M; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Liu Y; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Xing H; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Wang Z; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Shao Y; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.; Changping Laboratory, Beijing, China.
المصدر: Frontiers in immunology [Front Immunol] 2024 May 10; Vol. 15, pp. 1378048. Date of Electronic Publication: 2024 May 10 (Print Publication: 2024).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
مواضيع طبية MeSH: HIV Infections*/immunology , HIV Infections*/drug therapy , HIV Infections*/virology , HIV Infections*/blood , HIV-1*/immunology , Proteomics*/methods , Biomarkers*/blood , Viral Load*, Humans ; Male ; Adult ; Female ; Middle Aged ; China ; CD4 Lymphocyte Count ; HIV Long-Term Survivors ; Virus Replication/drug effects ; East Asian People
-
4دورية أكاديمية
المؤلفون: Rallón N; HIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Hospital Universitario Rey Juan Carlos, Móstoles, Spain., Jiménez-Carretero D; Unidad de Bioinformática, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., Restrepo C; HIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Hospital Universitario Rey Juan Carlos, Móstoles, Spain., Ligos JM; Cytek Biosciences Inc., Fremont, California., Valentín-Quiroga J; Grupo de respuesta inmune innata, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain., Mahillo I; Department of Statistics, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain., Cabello A; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., López-Collazo E; Grupo de respuesta inmune innata, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain., Sánchez-Cabo F; Unidad de Bioinformática, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., Górgolas M; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Estrada V; Hospital Universitario Clínico San Carlos, Madrid, Spain., Benito JM; HIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Hospital Universitario Rey Juan Carlos, Móstoles, Spain.
مؤلفون مشاركون: ECRIS integrated in the Spanish AIDS Research Network
المصدر: Journal of medical virology [J Med Virol] 2024 May; Vol. 96 (5), pp. e29646.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE
مواضيع طبية MeSH: Killer Cells, Natural*/immunology , HIV Infections*/immunology , HIV Infections*/drug therapy , HIV Infections*/virology, Humans ; Male ; Adult ; Female ; Middle Aged ; Flow Cytometry ; HIV Long-Term Survivors ; CD56 Antigen/analysis ; Biomarkers ; Immunophenotyping ; Receptors, IgG ; Phenotype ; HIV-1/immunology ; GPI-Linked Proteins
-
5دورية أكاديمية
المؤلفون: Vieira VA; Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Adland E; Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Grayson NE; Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Csala A; Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Richards F; Department of Paediatrics, Kimberley Hospital, Kimberley, South Africa., Dacon C; Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Athavale R; Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Tsai MH; Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom., D'Souza R; Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Muenchhoff M; Max von Pettenkofer Institute & Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.; German Center for Infection Research, Munich, Germany., Bonsall D; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; Wellcome Centre for Human Genetics, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Jooste P; Department of Paediatrics, Kimberley Hospital, Kimberley, South Africa., Goulder PJR; Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
المصدر: Journal of virology [J Virol] 2022 Jan 26; Vol. 96 (2), pp. e0153521. Date of Electronic Publication: 2021 Nov 10.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE
مواضيع طبية MeSH: HIV Long-Term Survivors*, HIV Infections/*immunology , Viremia/*immunology, Adolescent ; CD4 Lymphocyte Count ; CD8-Positive T-Lymphocytes/immunology ; Child ; Child, Preschool ; Female ; HIV Infections/virology ; HIV-1/genetics ; HIV-1/immunology ; HLA-B Antigens/immunology ; Humans ; Immune Evasion ; Immunodominant Epitopes/genetics ; Immunodominant Epitopes/immunology ; Infant ; Male ; Viral Load ; Viremia/virology ; Virus Replication ; gag Gene Products, Human Immunodeficiency Virus/genetics ; gag Gene Products, Human Immunodeficiency Virus/immunology
-
6دورية أكاديمية
المؤلفون: Romaru J; Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Reims University Hospital, Reims, France., Bahuaud M; Plateforme d'Immunomonitoring Vaccinal, Laboratory of Immunology, Cochin Hospital and University Paris-Descartes, APHP, Paris, France., Lejeune G; Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Reims University Hospital, Reims, France.; Department of Internal Medicine and Infectious Diseases, CH de Charleville-Mézières, Charleville-Mézières, France., Hentzien M; Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Reims University Hospital, Reims, France., Berger JL; Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Reims University Hospital, Reims, France., Robbins A; Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Reims University Hospital, Reims, France.; Laboratory of Immunology, EA7509 IRMAIC, University of Reims Champagne-Ardenne (URCA), Reims, France., Lebrun D; Department of Internal Medicine and Infectious Diseases, CH de Charleville-Mézières, Charleville-Mézières, France., N'Guyen Y; Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Reims University Hospital, Reims, France., Bani-Sadr F; Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Reims University Hospital, Reims, France., Batteux F; Plateforme d'Immunomonitoring Vaccinal, Laboratory of Immunology, Cochin Hospital and University Paris-Descartes, APHP, Paris, France., Servettaz A; Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Reims University Hospital, Reims, France.; Laboratory of Immunology, EA7509 IRMAIC, University of Reims Champagne-Ardenne (URCA), Reims, France.
المصدر: Frontiers in immunology [Front Immunol] 2021 Dec 20; Vol. 12, pp. 791147. Date of Electronic Publication: 2021 Dec 20 (Print Publication: 2021).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
مواضيع طبية MeSH: HIV Long-Term Survivors* , Immunogenicity, Vaccine* , Vaccination* , Vaccine Efficacy*, HIV Infections/*immunology , Pneumococcal Infections/*prevention & control , Pneumococcal Vaccines/*administration & dosage, Adult ; Antibodies, Bacterial/blood ; Biological Assay ; Biomarkers/blood ; CD4 Lymphocyte Count ; Enzyme-Linked Immunosorbent Assay ; Female ; France ; HIV Infections/diagnosis ; HIV Infections/virology ; HL-60 Cells ; Humans ; Immunocompromised Host ; Male ; Middle Aged ; Opsonization ; Pneumococcal Infections/immunology ; Pneumococcal Infections/microbiology ; Pneumococcal Vaccines/immunology ; Prospective Studies ; Time Factors ; Treatment Outcome
-
7دورية أكاديمية
المؤلفون: Levitt DE; Comprehensive Alcohol-HIV/AIDS Research Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana.; Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana., Ferguson TF; Comprehensive Alcohol-HIV/AIDS Research Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana.; Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana.; Department of Epidemiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana., Primeaux SD; Comprehensive Alcohol-HIV/AIDS Research Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana.; Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana.; Joint Diabetes, Endocrinology & Metabolism Center, Pennington Biomedical Research Center, Baton Rouge, Louisiana., Zavala JA; Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana., Ahmed J; Section of Cardiology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana., Marshall RH; Department of Radiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana., Simon L; Comprehensive Alcohol-HIV/AIDS Research Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana.; Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana., Molina PE; Comprehensive Alcohol-HIV/AIDS Research Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana.; Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana.
المصدر: American journal of physiology. Regulatory, integrative and comparative physiology [Am J Physiol Regul Integr Comp Physiol] 2021 Nov 01; Vol. 321 (5), pp. R781-R790. Date of Electronic Publication: 2021 Sep 29.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1490 (Electronic) Linking ISSN: 03636119 NLM ISO Abbreviation: Am J Physiol Regul Integr Comp Physiol Subsets: MEDLINE
مواضيع طبية MeSH: Energy Metabolism* , HIV Long-Term Survivors*, Alcohol Drinking/*adverse effects , Blood Glucose/*metabolism , Diabetes Mellitus, Type 2/*blood , HIV Infections/*metabolism , Mitochondria, Muscle/*metabolism , Myoblasts, Skeletal/*metabolism , Quadriceps Muscle/*metabolism, Adult ; Alcohol Drinking/blood ; Alcohol Drinking/epidemiology ; Alcohol Drinking/physiopathology ; Biomarkers/blood ; Cells, Cultured ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/physiopathology ; Female ; HIV Infections/epidemiology ; HIV Infections/physiopathology ; Humans ; Insulin Resistance ; Louisiana/epidemiology ; Male ; Middle Aged ; Oxygen Consumption ; Quadriceps Muscle/physiopathology ; Risk Assessment ; Risk Factors ; Young Adult
-
8دورية أكاديمية
المؤلفون: Yanes-Lane M; Respiratory Epidemiology and Clinical Research Unit, McGill International TB Centre, McGill University, Montréal, Québec, Canada., Ortiz-Brizuela E; Respiratory Epidemiology and Clinical Research Unit, McGill International TB Centre, McGill University, Montréal, Québec, Canada.; Department of Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Campbell JR; Respiratory Epidemiology and Clinical Research Unit, McGill International TB Centre, McGill University, Montréal, Québec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada., Benedetti A; Respiratory Epidemiology and Clinical Research Unit, McGill International TB Centre, McGill University, Montréal, Québec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.; Department of Medicine, McGill University, Montreal, Canada., Churchyard G; The Aurum Institute, Parktown, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa., Oxlade O; Respiratory Epidemiology and Clinical Research Unit, McGill International TB Centre, McGill University, Montréal, Québec, Canada., Menzies D; Respiratory Epidemiology and Clinical Research Unit, McGill International TB Centre, McGill University, Montréal, Québec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
المصدر: PLoS medicine [PLoS Med] 2021 Sep 14; Vol. 18 (9), pp. e1003738. Date of Electronic Publication: 2021 Sep 14 (Print Publication: 2021).
نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE
مواضيع طبية MeSH: Coinfection* , HIV Long-Term Survivors* , Preventive Health Services*, Anti-Retroviral Agents/*therapeutic use , Antitubercular Agents/*therapeutic use , HIV Infections/*drug therapy , Tuberculosis/*prevention & control, Adolescent ; Adult ; Aged ; Anti-Retroviral Agents/adverse effects ; Antitubercular Agents/adverse effects ; Child ; Child, Preschool ; Female ; HIV Infections/diagnosis ; HIV Infections/epidemiology ; HIV Infections/virology ; Humans ; Infant ; Isoniazid/therapeutic use ; Male ; Middle Aged ; Rifamycins/therapeutic use ; Risk Assessment ; Risk Factors ; Treatment Outcome ; Tuberculosis/diagnosis ; Tuberculosis/epidemiology ; Tuberculosis/microbiology ; Young Adult
-
9دورية أكاديمية
المؤلفون: Uppal A; Montréal Chest Institute, Montréal, Québec, Canada.; Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montréal, Québec, Canada.; McGill International Tuberculosis Centre, Montréal, Québec, Canada., Rahman S; Montréal Chest Institute, Montréal, Québec, Canada.; Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montréal, Québec, Canada.; McGill International Tuberculosis Centre, Montréal, Québec, Canada., Campbell JR; Montréal Chest Institute, Montréal, Québec, Canada.; Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montréal, Québec, Canada.; McGill International Tuberculosis Centre, Montréal, Québec, Canada., Oxlade O; McGill International Tuberculosis Centre, Montréal, Québec, Canada., Menzies D; Montréal Chest Institute, Montréal, Québec, Canada.; Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montréal, Québec, Canada.; McGill International Tuberculosis Centre, Montréal, Québec, Canada.
المصدر: PLoS medicine [PLoS Med] 2021 Sep 14; Vol. 18 (9), pp. e1003712. Date of Electronic Publication: 2021 Sep 14 (Print Publication: 2021).
نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE
مواضيع طبية MeSH: Coinfection* , Drug Costs* , HIV Long-Term Survivors*, Anti-Retroviral Agents/*therapeutic use , Antitubercular Agents/*economics , Antitubercular Agents/*therapeutic use , HIV Infections/*drug therapy , Preventive Health Services/*economics , Tuberculosis/*prevention & control, Anti-Retroviral Agents/adverse effects ; Anti-Retroviral Agents/economics ; Antitubercular Agents/adverse effects ; Cost-Benefit Analysis ; HIV Infections/diagnosis ; HIV Infections/economics ; HIV Infections/epidemiology ; Humans ; Incidence ; Models, Economic ; Risk Assessment ; Risk Factors ; Treatment Outcome ; Tuberculosis/diagnosis ; Tuberculosis/economics ; Tuberculosis/epidemiology
-
10دورية أكاديمية
المؤلفون: Auld AF; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Kerkhoff AD; Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital and Trauma Center, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America., Hanifa Y; TB Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom., Wood R; The Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa., Charalambous S; Aurum Institute, Johannesburg, South Africa., Liu Y; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Agizew T; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana., Mathoma A; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana.; University of Botswana, Gaborone, Botswana., Boyd R; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana., Date A; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Shiraishi RW; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Bicego G; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Mathebula-Modongo U; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana., Alexander H; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Serumola C; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana., Rankgoane-Pono G; Ministry of Health and Wellness, Gaborone, Botswana., Pono P; Ministry of Health and Wellness, Gaborone, Botswana., Finlay A; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana., Shepherd JC; Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana.; Yale University School of Medicine, New Haven, Connecticut, United States of America., Ellerbrock TV; Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Grant AD; TB Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom.; Africa Health Research Institute, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa., Fielding K; TB Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom.
المصدر: PLoS medicine [PLoS Med] 2021 Sep 07; Vol. 18 (9), pp. e1003739. Date of Electronic Publication: 2021 Sep 07 (Print Publication: 2021).
نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.; Validation Study
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE
مواضيع طبية MeSH: Coinfection* , HIV Long-Term Survivors* , Mass Screening* , Preventive Health Services*, Anti-Retroviral Agents/*therapeutic use , Antitubercular Agents/*therapeutic use , HIV Infections/*drug therapy , Tuberculosis/*prevention & control, Adult ; Anti-Retroviral Agents/adverse effects ; Antitubercular Agents/adverse effects ; Botswana/epidemiology ; Clinical Trials as Topic ; Early Diagnosis ; Female ; HIV Infections/diagnosis ; HIV Infections/epidemiology ; HIV Infections/virology ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Prevalence ; Prognosis ; Reproducibility of Results ; Risk Assessment ; Risk Factors ; Tuberculosis/diagnosis ; Tuberculosis/epidemiology ; Tuberculosis/microbiology